Role of maintenance treatment in opioid dependence

Citation
J. Ward et al., Role of maintenance treatment in opioid dependence, LANCET, 353(9148), 1999, pp. 221-226
Citations number
75
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
LANCET
ISSN journal
01406736 → ACNP
Volume
353
Issue
9148
Year of publication
1999
Pages
221 - 226
Database
ISI
SICI code
0140-6736(19990116)353:9148<221:ROMTIO>2.0.ZU;2-X
Abstract
Methadone maintenance treatment (MMT) involves the daily administration of the oral opioid agonist methadone as a treatment for opioid dependence-a pe rsistent disorder with a substantial risk of premature death. MMT improves health and reduces illicit heroin use, infectious-disease transmission, and overdose death. However, its effectiveness is compromised if low maintenan ce doses of methadone (<60 mg) are used and patients are pressured to becom e prematurely abstinent from methadone. Pregnancy and psychiatric comorbidi ty are not contraindications for MMT. As an alternative to MMT, other oral opioid agents (eg, naltrexone, buprenorphine) may increase patient choice a nd avoid some of the more unpleasant aspects of MMT. The public-health chal lenge for the future is to develop and continue to deliver safe and effecti ve forms of opioid maintenance treatment to as many opioid-dependent indivi duals as can benefit from them.